4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The effect of an exercise program in pregnancy on vitamin D status among healthy, pregnant Norwegian women: a randomized controlled trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Vitamin D insufficiency is common in pregnant women worldwide. Regular prenatal exercise is considered beneficial for maternal and fetal health. There is a knowledge gap regarding the impact of prenatal exercise on maternal vitamin D levels.

          The objective of this study was to investigate whether a prenatal exercise program influenced serum levels of total, free and bioavailable 25-hydroxyvitamin D (25(OH)D) and related parameters. This is a post hoc analysis of a randomized controlled trial with gestational diabetes as the primary outcome.

          Methods

          Healthy, pregnant women from two Norwegian cities (Trondheim and Stavanger) were randomly assigned to a 12-week moderate -intensity exercise program (Borg perceived rating scale 13–14) or standard prenatal care. The intervention group ( n = 429) underwent exercise at least three times weekly; one supervised group training and two home based sessions. The controls ( n = 426) received standard prenatal care, and exercising was not denied. Training diaries and group training was used to promote compliance and evaluate adherence. Serum levels of 25(OH)D, parathyroid hormone, calcium, phosphate, magnesium and vitamin D-binding protein were measured before (18–22 weeks′ gestation) and after the intervention (32–36 weeks′ gestation). Free and bioavailable 25(OH)D concentrations were calculated. Regression analysis of covariance (ANCOVA) was applied to assess the effect of the training regime on each substance with pre-intervention levels as covariates. In a second model, we also adjusted for study site and sampling month. Intention-to-treat principle was used.

          Results

          A total of 724 women completed the study. No between-group difference in serum 25(OH)D and related parameters was identified by ANCOVA using baseline serum levels as covariates. The second model revealed a between-group difference in levels of 25(OH)D (1.9, 95% CI 0.0 to 3.8 nmol/L; p = 0.048), free 25(OH)D (0.55, 95% CI 0.10 to 0.99 pmol/L; p = 0.017) and bioavailable 25(OH)D (0.15 95% CI 0.01 to 0.29 nmol/L; p = 0.036). No serious adverse events related to regular exercise were seen.

          Conclusion

          This study, a post hoc analysis, indicates that exercise may affect vitamin D status positively, and emphasizes that women with uncomplicated pregnancies should be encouraged to perform regular exercise.

          Trial registration

          ClinicalTrials.gov: NCT00476567, registered May 22, 2007.

          Electronic supplementary material

          The online version of this article (10.1186/s12884-019-2220-z) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: found

          The Global Burden of Obesity and the Challenges of Prevention

          The prevalence of obesity is increasing at an alarming rate in many parts of the world. About 2 billion people are overweight and one third of them obese. The plight of the most affected populations, like those in high-income countries in North America, Australasia and Europe, has been well publicized. However, the more recent increases in population obesity in low- and middle-income countries that are now increasingly being observed have been less recognized. Based on the existing prevalence and trend data and the epidemiological evidence linking obesity with a range of physical and psychosocial health conditions, it is reasonable to describe obesity as a public health crisis that severely impairs the health and quality of life of people and adds considerably to national health-care budgets. Intersectoral action to manage and prevent obesity is urgently required to reverse current trends.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sample size slippages in randomised trials: exclusions and the lost and wayward.

            Proper randomisation means little if investigators cannot include all randomised participants in the primary analysis. Participants might ignore follow-up, leave town, or take aspartame when instructed to take aspirin. Exclusions before randomisation do not bias the treatment comparison, but they can hurt generalisability. Eligibility criteria for a trial should be clear, specific, and applied before randomisation. Readers should assess whether any of the criteria make the trial sample atypical or unrepresentative of the people in which they are interested. In principle, assessment of exclusions after randomisation is simple: none are allowed. For the primary analysis, all participants enrolled should be included and analysed as part of the original group assigned (an intent-to-treat analysis). In reality, however, losses frequently occur. Investigators should, therefore, commit adequate resources to develop and implement procedures to maximise retention of participants. Moreover, researchers should provide clear, explicit information on the progress of all randomised participants through the trial by use of, for instance, a trial profile. Investigators can also do secondary analyses on, for instance, per-protocol or as-treated participants. Such analyses should be described as secondary and non-randomised comparisons. Mishandling of exclusions causes serious methodological difficulties. Unfortunately, some explanations for mishandling exclusions intuitively appeal to readers, disguising the seriousness of the issues. Creative mismanagement of exclusions can undermine trial validity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery.

              During pregnancy and lactation, female physiology adapts to meet the added nutritional demands of fetuses and neonates. An average full-term fetus contains ∼30 g calcium, 20 g phosphorus, and 0.8 g magnesium. About 80% of mineral is accreted during the third trimester; calcium transfers at 300-350 mg/day during the final 6 wk. The neonate requires 200 mg calcium daily from milk during the first 6 mo, and 120 mg calcium from milk during the second 6 mo (additional calcium comes from solid foods). Calcium transfers can be more than double and triple these values, respectively, in women who nurse twins and triplets. About 25% of dietary calcium is normally absorbed in healthy adults. Average maternal calcium intakes in American and Canadian women are insufficient to meet the fetal and neonatal calcium requirements if normal efficiency of intestinal calcium absorption is relied upon. However, several adaptations are invoked to meet the fetal and neonatal demands for mineral without requiring increased intakes by the mother. During pregnancy the efficiency of intestinal calcium absorption doubles, whereas during lactation the maternal skeleton is resorbed to provide calcium for milk. This review addresses our current knowledge regarding maternal adaptations in mineral and skeletal homeostasis that occur during pregnancy, lactation, and post-weaning recovery. Also considered are the impacts that these adaptations have on biochemical and hormonal parameters of mineral homeostasis, the consequences for long-term skeletal health, and the presentation and management of disorders of mineral and bone metabolism.
                Bookmark

                Author and article information

                Contributors
                +47 480 50 175 , miriam.gustafsson@ntnu.no
                pal.romundstad@ntnu.no
                signe.n.stafne@ntnu.no
                anne-sofie.helvik@ntnu.no
                kamilla.stunes@ntnu.no
                siv.morkved@ntnu.no
                pepe.salvesen@ntnu.no
                pertho@ous-hf.no
                mats.p.mosti@ntnu.no
                unni.syversen@ntnu.no
                Journal
                BMC Pregnancy Childbirth
                BMC Pregnancy Childbirth
                BMC Pregnancy and Childbirth
                BioMed Central (London )
                1471-2393
                20 February 2019
                20 February 2019
                2019
                : 19
                : 76
                Affiliations
                [1 ]ISNI 0000 0001 1516 2393, GRID grid.5947.f, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, , Norwegian University of Science and Technology (NTNU), ; PO Box 8905, 7491 Trondheim, Norway
                [2 ]ISNI 0000 0004 0627 3560, GRID grid.52522.32, Division of Mental Health Care, , Trondheim University Hospital (St. Olavs hospital), ; Trondheim, Norway
                [3 ]ISNI 0000 0004 0627 3560, GRID grid.52522.32, Clinic of Clinical Services, , Trondheim University Hospital (St. Olavs hospital), ; Trondheim, Norway
                [4 ]ISNI 0000 0004 0627 3560, GRID grid.52522.32, Trondheim University Hospital (St. Olavs hospital), ; Trondheim, Norway
                [5 ]ISNI 0000 0001 1516 2393, GRID grid.5947.f, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, , Norwegian University of Science and Technology (NTNU), ; Trondheim, Norway
                [6 ]ISNI 0000 0004 0627 3560, GRID grid.52522.32, Department of Obstretics and Gynaecology, , Trondheim University Hospital (St. Olavs hospital), ; Trondheim, Norway
                [7 ]ISNI 0000 0004 0389 8485, GRID grid.55325.34, Hormone Laboratory, Department of Medical Biochemistry, , Oslo University Hospital, ; Aker sykehus, Oslo, Norway
                [8 ]ISNI 0000 0004 0627 3560, GRID grid.52522.32, Department of Endocrinology, , Trondheim University Hospital (St. Olavs hospital), ; Trondheim, Norway
                Author information
                http://orcid.org/0000-0003-4151-393X
                Article
                2220
                10.1186/s12884-019-2220-z
                6381613
                30786861
                442d18e9-bcb5-4682-bf8f-0f404367af1c
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 10 August 2018
                : 11 February 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100004590, Helse Midt-Norge;
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2019

                Obstetrics & Gynecology
                bioavailable 25(oh)d,exercise,free 25(oh)d,physical activity,pregnancy,rct,serum 25(oh)d

                Comments

                Comment on this article